← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Natriumhydrogencarbonat currently has availability issues reported in 1 European register: Germany.
Shortage ATC A02AH · also listed as: Natriumhydrogencarbonat · data refreshed 29 September 2026
As of 29 September 2026, 1 of the 10 tracked registers list current availability issues for Natriumhydrogencarbonat, covering 2 affected product presentations. Where agencies state a cause, unexpectedly high demand lead with 1 of the 2 stated-cause reports, followed by manufacturing problems with 1. The furthest expected-resolution date currently on file is 2027-06-15; the earliest is 2027-01-31. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Natriumhydrogencarbonat is coded A02AH — a medicine acting on alimentary tract and metabolism — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Anatrofer 1000 mg magensaftresistente Tabletten + 1 more productsbicaNorm | 2026-08-11 | 2027-06-15 | Erhöhte Nachfrage Alternatives: N/A | register ↗ |
Every individual register entry for Natriumhydrogencarbonat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Anatrofer 1000 mg magensaftresistente Tabletten | Shortage | 2026-08-25 | 2027-01-31 | Erhöhte Nachfrage |
| 🇩🇪 DE | bicaNorm | Shortage | 2026-08-11 | 2027-06-15 | Probleme in der Herstellung |
Yes. As of 29 September 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2027-01-31 to 2027-06-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Natriumhydrogencarbonat: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Natriumhydrogencarbonat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/natriumhydrogencarbonat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Natriumhydrogencarbonat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/natriumhydrogencarbonat/">Natriumhydrogencarbonat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>